포함된 환자는 233명(다파글리플로진 병용 환자 79명 및 DPP4i 병용 환자 154명)이었으며 다음 환자는 제외되었다.
Included patients were 233 (79 dapagliflozin combined patients and 154 DPP4i combined patients) and following patients were excluded.